Clinical Trial Update: EPOMI Study: ErythroPOietin in Myocardial Infarction [Phase 2]

View source ↗

Summary

EPOMI is a Phase 2 study of erythropoietin in patients with myocardial infarction that has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction

Drugs mentioned

• Erythropoietin (erythropoietin)

Snippet

Sponsor: University Hospital, Angers | Conditions: Myocardial Infarction | Phase 2 | Status: COMPLETED